The present study demonstrates that IFITM3 is preferentially expressed in GSCs and decreased markedly in differentiated glioma cells, yet has no significant impact on GSC self-renewal ability (Fig. 3A). This evidence concerns the gene IFITM3 and central nervous system cancer.